A post hoc analysis of PROTECT VIII kids assessing long-term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A.

Sanjay Ahuja Tina T BissMonika Maas EnriquezMaria Elisa Mancuso MacGregor Steele Gili Kenet

Published in: European journal of haematology (2024)

Damoctocog alfa pegol is efficacious with a favourable safety profile in adolescents with haemophilia A, supporting its long-term use in children and adolescents.

Keyphrases

young adults
physical activity
replacement therapy
early onset